FDA Announces New Initiative for Real-Time Clinical Trials
Date: June 23, 2026
The U.S. Food and Drug Administration (FDA) has announced a new initiative to support the implementation of real-time clinical trials, with pilot studies exploring how regulators can review clinical trial data as it becomes available.
For clinical data management professionals, the announcement highlights the increasing importance of high-quality, timely and well-governed data to support evolving approaches to clinical research.
Read the full FDA announcement to learn more about the initiative and its potential impact on the future of clinical trials: https://www.fda.gov/news-events/press-announcements/fda-announces-major-steps-implement-real-time-clinical-trials
